In an update Tuesday, Pfizer said it is discontinuing 15 of the projects in its development pipeline. The news comes a month after the world’s largest pharmaceutical company announced large research and development cuts were on the way.
Continue reading Pfizer Shrinks Its Drug Pipeline Amid R&D Cuts
Pfizer Shrinks Its Drug Pipeline Amid R&D Cuts originally appeared on DailyFinance on Tue, 01 Mar 2011 20:00:00.
Filed Under: Health Care, Pfizer